3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Sleep Wake Disorders
1
Sleep Disorders, Circadian Rhythm
1
Radiodermatitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Keratosis, Actinic
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Depression
1
Delirium
1
Brain Neoplasms
1
Brain Concussion
1
Interventions
triethanolamine
1
calcipotriene
1
Triamcinolone Acetonide
1
Radiotherapy, Conformal
1
Radiotherapy
1
Melatonin
1
Dimethyl Sulfoxide
1
Curcumin
1
Biafine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Radiodermatitis
×
Melatonin
×
Clear all
NCT03716583
2021-09-10
MELADERM
Herlev Hospital
Phase 2
Completed
48 enrolled